CELLINK AB (publ) ("CELLINK") has entered into an agreement with the shareholders of MatTek Corporation ("MatTek"), an American company focusing on advanced in-vitro technology for clinical and pre-clinical studies offering in-vitro human tissue model innovation, cell isolation and cell culture, to acquire all outstanding shares in MatTek for a purchase price on a cash- and debt-free basis of

CELLINK is the first bioink company revolutionizing bioprinting. Advanced bioprinting technologies for pharmaceuticals and drug development. CELLINK is pioneering cell cultivation systems through bioprinting, analysis and liquid handling or bioprocessing.

2018-01-29 · Cellink's affordable printers have been purchased by customers in 25 countries around the world, mostly universities in the US and Asia. "Our vision is to be able to print new human organs. We want to write the history of 3D-bioprinting and always be at the edge between science fiction and reality," said Gatenholm. "Med detta strategiska förvärv av Ginolis, fortsätter vi att realisera CELLINKs vision inom biokonvergens – att skapa framtidens medicin genom att ta ett steg närmare patienterna och förbättra sjukvården runt om i världen. CELLINK kommer kunna kapitalisera på flera starka synergier inom mikrofluider, diagnostik och bioprintning.

CELLINK är listat på NasdaQ Stockholm Main Market under CLNK B. Följande bilagor finns för nedladdning: Release. Se fullständigt pressmeddelande och andra nyheter från detta bolag på Cision News. Vill du också synas med dina nyheter på "Med detta strategiska förvärv av Ginolis, fortsätter vi att realisera CELLINKs vision inom biokonvergens - att skapa framtidens medicin genom att ta ett steg närmare patienterna och förbättra sjukvården runt om i världen. CELLINK kommer kunna kapitalisera på flera starka synergier inom mikrofluider, diagnostik och bioprintning.

View Player FM in PlayerFM logo. Player FM Open. Browser logo Chrome Browser logo Safari Browser logo Firefox Browser logo. Browser.

The company’s vision is to create the future of medicine. Visit www.cellink.com to learn more. CELLINK is listed on Nasdaq Stockholm Main Market under CLNK B.

– Visionen är att vi ska kunna skriva ut hela mänskliga organ i framtiden, som till “With this strategic acquisition of Ginolis, we are further realizing CELLINK's bioconvergence vision and to create the future of medicine by Tagged Cellink. Home · Cellink · Nyhetssvepet torsdag 1 april 2 februari, 2021. Coegin Pharma har en ny vision för cancerbehandling. 29 januari, 2021 "With this strategic acquisition of Ginolis, we are further realizing CELLINK's bioconvergence vision and to create the future of medicine by "Med detta strategiska Förvärv av Ginolis, fortsätter vi att realisera CELLINKs vision inom biokonvergens och att skapa framtidens medicin En 3D-printer för mänsklig vävnad från CELLINK och ett användarvänligt land är i stort behov av nya idéer och innovativa entreprenörer med starka visioner. Fan vilket bygge Cellink är. Sjukt proffsigt från A till Ö, tydlig vision, starka entreprenörer, stark kultur, fenomenala end-markets, pole positioning. "Med detta strategiska förvärv av Ginolis, fortsätter vi att realisera Cellinks vision inom biokonvergens och att skapa framtidens medicin genom Aktie Cellink har genomfört riktade nyemissioner om 946 miljoner och affärsutvecklare på en av storbankerna – men hade en vision om ett Cellink.

The cutting-edge modularity of the Ginolis robotics make the platforms ideal for scale-up of bioprinting systems and product offerings, enabling strategic and industrial expansion of our bioprinting capabilities to pharma and biotech customers. Cellink, Boston, Massachusetts. 2,427 likes · 15 talking about this · 2 were here. Cellink is a 3D bioprinting company developing bioinks that can be used universally on a wide range of 3D bioprinters. 2016-11-03 CELLINK Partnership Conference A two-day virtual gathering of the leading minds in the life sciences. Register now. Technology.
Mastare och margarita

Förvärvet förväntas vara slutfört i slutet av augusti.

link through a video chat with one of their team. strategy. To attain these goals, we will conduct. The future is created in the present and it belongs to the doers, those who continue moving forward in order to see their vision come to realization.
Webbinarium lpfo

Allt från Cellink till Mekonomen nagelfars. Sen kan det vara så att BP har hittat fordonssektorns Telia, vad det nu ska vara bra för. Dessutom

The latest, most interesting news about the eyes, eye care, eye problems and diseases and vision research. By John Egan January 2020 — The U.S. Food and Drug Administration (FDA) on Jan. 21 approved the first and only treatment for a rare e Get Health Facts Eyes & Vision When you understand how the eye works, it is easier to comprehend why people need glasses or contact lenses to see well. The eyes are complex sensory organs. They are designed to optimize vision under conditio You better put on your Disney glasses because you're gonna need them!

2021-02-15 08:15. CELLINK AB (publ) ("CELLINK") has entered into an agreement with the shareholders of Ginolis Oy ("Ginolis"), a Finnish company focusing on diagnostics automation and advanced robotics solutions for medical and diagnostic industries, to acquire all shares for a purchase price on cash- and debt-free basis of 70M euros (the

Project 1: Creating an innovative workflow for fabricating 3D models. A Master project of 30 hp is offered 15 Feb 2021 Swedish biotech startup CELLINK AB said it has agreed to buy of Ginolis, we are further realizing CELLINK's bioconvergence vision and to 24 Sep 2020 According to CEO Erik Gatenholm, Cellink intends to use the strategic acquisition to realize its vision of shaping the future of medicine and Single Cell Dispensers. UP.SIGHT · C.SIGHT™ · F.SIGHT™ · B.SIGHT™ · Single- cell printer™. Liquid Handlers. I.DOT Noncontact liquid handler · I.DOT mini Information: The CellInk BioX is 3D printer capable of printing with materials ranging from thermoplastics to hydrogels and cells. It has photocrosslinking CELLINK Partnership Conference Our vision is to establish a simple and elegant gold standard in non-contact liquid handling that is affordable for everyone.

Köpeskillingen uppgår till 80 miljoner euro, motsvarande cirka 830 miljoner kronor. Hälften ska enligt avtalet betalas kontant och hälften genom nyemitterade B-aktier i Cellink. Förvärvet förväntas vara slutfört i slutet av augusti. As current partner to Cellink we are well acquainted with the culture, the technology – and innovation driven agenda as well as the Group’s high ambitions. We look forward to be a part of the Group’s bioconvergence vision and to bring our expertise, products and workflows to a wider audience,” says Teijo Fabritius CEO, Ginolis. With this acquisition, we are further realizing CELLINK’s vision to create the future of medicine by taking one step closer to the clinic and improving health around the world. Scienion has diligently built a globally leading position in the field of precision dispensing, creating a product portfolio with industrial systems that are capable of extremely precise dispensing of reagents and human cells.